| Autor: |
Shrawan Kumar Mandal, Jenish Neupane, Ajay M. V. Kumar, Hayk Davtyan, Pruthu Thekkur, Anup Jayaram, Bimal Sharma Chalise, Manisha Rawal, Manu Paudel, Bishwodip Baral, Rajesh Kumar Shah, Kijan Maharjan, Sanjay Shrestha, Lilanath Bhandari, Nisha K.C., Nabaraj Gautam, Avinash K. Sunny, Nishant Thakur, Koshal Chandra Subeedee, Sushil Kumar Mandal, Anup Bastola |
| Jazyk: |
angličtina |
| Rok vydání: |
2022 |
| Předmět: |
|
| Zdroj: |
Tropical Medicine and Infectious Disease, Vol 7, Iss 11, p 381 (2022) |
| Druh dokumentu: |
article |
| ISSN: |
2414-6366 |
| DOI: |
10.3390/tropicalmed7110381 |
| Popis: |
Like the world over, Nepal was also hard hit by the second wave of COVID-19. We audited the clinical care provided to COVID-19 patients admitted from April to June 2021 in a tertiary care hospital of Nepal. This was a cohort study using routinely collected hospital data. There were 620 patients, and most (458, 74%) had severe illness. The majority (600, 97%) of the patients were eligible for admission as per national guidelines. Laboratory tests helping to predict the outcome of COVID-19, such as D-dimer and C-reactive protein, were missing in about 25% of patients. Nearly all (>95%) patients with severe disease received corticosteroids, anticoagulants and oxygen. The use of remdesivir was low (22%). About 70% of the patients received antibiotics. Hospital exit outcomes of most (>95%) patients with mild and moderate illness were favorable (alive and discharged). Among patients with severe illness, about 25% died and 4% were critically ill, needing further referral. This is the first study from Nepal to audit and document COVID-19 clinical care provision in a tertiary care hospital, thus filling the evidence gap in this area from resource-limited settings. Adherence to admission guidelines was excellent. Laboratory testing, access to essential drugs and data management needs to be improved. |
| Databáze: |
Directory of Open Access Journals |
| Externí odkaz: |
|
